133 related articles for article (PubMed ID: 86469)
1. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
Khoo SK; Daunter B; Mackay E
Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
[No Abstract] [Full Text] [Related]
3. Serum beta 2--microglobulin and carcinoembryonic antigen in patients with gastric disorders.
Satake K; Kitamura T; Ishikawa T; Mukai R; Yoshimoto T; Chung YS; Umeyama K
J Surg Oncol; 1981; 17(3):225-33. PubMed ID: 6166812
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum beta 2-microglobulin and carcinoembryonic antigen in patients with cervical cancer treated with irradiation (author's transl)].
Sato Y; Tottori K; Higuchi A; Takeuchi S
Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):306-12. PubMed ID: 90106
[No Abstract] [Full Text] [Related]
5. [Comparison of serum levels of beta2-microglobulin and carcino-embryonic antigen in the follow-up of lung cancer (author's transl)].
Ardiet C; Gonthier R; Pasquet P; Lahneche B
Pathol Biol (Paris); 1978 Sep; 26(6):355-7. PubMed ID: 83584
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum tumor markers in patients with carcinoma of the ovary.
Kikuchi Y; Kizawa I; Koyama E; Kato K
Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
Fenoglio CM; Crum CP; Pascal RR; Richart RM
Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
Higuchi Y
Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
[TBL] [Abstract][Full Text] [Related]
9. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
10. [beta2-Microglobulin and carcino-embryonic antigen in bronchogenic carcinoma (author's transl)].
Bisset JP; Poirier R; Roux F; Sauvan R; Kleisbauer JP
Pathol Biol (Paris); 1978 Sep; 26(6):353-4. PubMed ID: 83583
[TBL] [Abstract][Full Text] [Related]
11. Is serum beta 2-microglobulin a tumor marker in gastrointestinal cancer?
Staab HJ; Anderer FA; Hiesche K; Wehrle E; Rodatz W
Clin Chim Acta; 1980 Oct; 106(3):309-17. PubMed ID: 6158388
[TBL] [Abstract][Full Text] [Related]
12. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of the combined determination of the plasma concentrations of beta 2m and of CEA in the primary diagnosis and the control of radical surgery of adenocarcinoma of the gastrointestinal tract (author's transl)].
Auer IO; Wätzel C; Hiesche K
Klin Wochenschr; 1980 Dec; 58(23):1313-7. PubMed ID: 6162055
[No Abstract] [Full Text] [Related]
15. Simultaneous plasma determination of CEA, HCG-beta and beta-2-microglobulin in patients with nontrophoblastic tumors.
Ruibal A; Gultresa J
Tumori; 1980 Jun; 66(3):305-9. PubMed ID: 6160667
[TBL] [Abstract][Full Text] [Related]
16. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
17. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
18. [beta2-Microglobulin in cancer patients (author's transl)].
Daver A; Chassevent A; Bouali AB; Bertrand AF; Deroche C; Cellier P; Tuchais C; Souaille C; Maillart P; Bertrand G; Minier JF; Larra F; Agerup B
Pathol Biol (Paris); 1978 Sep; 26(6):335-40. PubMed ID: 83577
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
20. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
Anger H; Gleissenberger U
Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
